Haemophilia A

The webinar moderated by Frank Leebeek focused on the practical issues associated with gene therapy, including the eligibility assessment process and the multidisciplinary team perspective on infusion...

Chaired by Niamh O'Connell, the ISTH 2022 symposium outlined the current care models and therapeutic options in haemophilia highlighting the need for a shift in care as new emerging therapies are bein...

Co-chaired by Ingrid Pabinger and Wolfgang Miesbach, the EHA 2022 symposium highlighted the current gene therapy landscape in bleeding disorders and the status of gene therapies in clinical trials for...

The EAHAD 2022 symposium highlighted the current haemophilia treatment landscape and what the future holds for haemophilia care, including managing change and shifting mindsets for a new treatment par...

Co-chaired by María Teresa Álvarez Román and Madlen Reschke, the EAHAD 2022 symposium highlighted the use of prophylaxis in paediatric patients with haemophilia, patients with mild or moderate haemoph...

The EAHAD 2021 symposium was chaired by Michiel Coppens and featured three pre-recorded presentations that highlight challenging obstacles to patient care in haemophilia A and B and von Willebrand dis...